NR3C2 and hydrops fetalis: There were some differences in HF therapy between groups (HFrEF vs. LVAD), beta‐blockade (70% vs. 39%, p = 0.054), and mineralocorticoid receptor antagonist (75% vs. 28%, p = 0.004).